View in EDS

Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Authors: Rago F; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Rodrigues LU; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Bonney M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Sprouffske K; Novartis Institutes for Biomedical Research, Basel, Switzerland., Kurth E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Elliott G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ambrose J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Aspesi P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Oborski J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Chen JT; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., McDonald ER; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Mapa FA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ruddy DA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Kauffmann A; Novartis Institutes for Biomedical Research, Basel, Switzerland., Abrams T; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Bhang HC; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Jagani Z; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2022 Mar 01; Vol. 20 (3), pp. 361-372.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34799403
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rago+F%22">Rago F</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rodrigues+LU%22">Rodrigues LU</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bonney+M%22">Bonney M</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sprouffske+K%22">Sprouffske K</searchLink>; Novartis Institutes for Biomedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kurth+E%22">Kurth E</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Elliott+G%22">Elliott G</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ambrose+J%22">Ambrose J</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Aspesi+P%22">Aspesi P</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Oborski+J%22">Oborski J</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chen+JT%22">Chen JT</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22McDonald+ER%22">McDonald ER</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mapa+FA%22">Mapa FA</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ruddy+DA%22">Ruddy DA</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kauffmann+A%22">Kauffmann A</searchLink>; Novartis Institutes for Biomedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Abrams+T%22">Abrams T</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bhang+HC%22">Bhang HC</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Jagani+Z%22">Jagani Z</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101150042%22">Molecular cancer research : MCR</searchLink> [Mol Cancer Res] 2022 Mar 01; Vol. 20 (3), pp. 361-372.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101150042 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215417786%22">15417786 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34799403
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1541-7786.MCR-21-0390
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 361
    Titles:
      – TitleFull: Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rago F
      – PersonEntity:
          Name:
            NameFull: Rodrigues LU
      – PersonEntity:
          Name:
            NameFull: Bonney M
      – PersonEntity:
          Name:
            NameFull: Sprouffske K
      – PersonEntity:
          Name:
            NameFull: Kurth E
      – PersonEntity:
          Name:
            NameFull: Elliott G
      – PersonEntity:
          Name:
            NameFull: Ambrose J
      – PersonEntity:
          Name:
            NameFull: Aspesi P
      – PersonEntity:
          Name:
            NameFull: Oborski J
      – PersonEntity:
          Name:
            NameFull: Chen JT
      – PersonEntity:
          Name:
            NameFull: McDonald ER
      – PersonEntity:
          Name:
            NameFull: Mapa FA
      – PersonEntity:
          Name:
            NameFull: Ruddy DA
      – PersonEntity:
          Name:
            NameFull: Kauffmann A
      – PersonEntity:
          Name:
            NameFull: Abrams T
      – PersonEntity:
          Name:
            NameFull: Bhang HC
      – PersonEntity:
          Name:
            NameFull: Jagani Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2022 Mar 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3125
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular cancer research : MCR
              Type: main
ResultId 1